Clinical Trial Update: A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic and safety study of GSK2894512 in healthy adult subjects has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• GSK2894512

Snippet

Sponsor: GlaxoSmithKline | Conditions: Psoriasis | Phase 1 | Status: WITHDRAWN